Vanessa Kay Votypka, CNP
Family · Palo Alto
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Vanessa Kay Votypka’s office at (415) 663-5584 to ask if they take your plan before you enroll.
Medicaid work
$783 in 2023
Medicaid paid $783 for 13 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 13 | $783 |
| 2023 | 13 | 1 | 13 | $783 |
| 2022 | 2,074 | 13 | 143 | $144,403 |
| 2021 | 181 | 5 | 21 | $11,044 |
| 2020 | 134 | 3 | 31 | $6,091 |
| 2019 | 1,085 | 5 | 84 | $58,649 |
| 2018 | 1,157 | 3 | 64 | $62,359 |
See the largest Medicaid services in earlier years
2022
| Return visit (30+ min) | 648 | $54,202 |
| Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected | 374 | $51,361 |
| Short return visit (20+ min) | 443 | $24,884 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 124 | $5,869 |
| Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, amplified probe technique | 191 | $5,402 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 17 | $1,766 |
| Developmental screening | 75 | $620 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 20 | $182 |
| Screening test, pure tone, air only | 41 | $104 |
| Bilateral quantitative screening test of visual acuity | 58 | $14 |
| BODY MASS INDEX DOCD | 44 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 17 | $0 |
2021
| Hospital outpatient clinic visit for assessment and management of a patient | 63 | $9,355 |
| Short return visit (20+ min) | 42 | $962 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 23 | $615 |
| Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes | 29 | $112 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted, for intramuscular use | 24 | $0 |
2020
| Hospital outpatient clinic visit for assessment and management of a patient | 38 | $4,530 |
| Short return visit (20+ min) | 39 | $927 |
| Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes | 57 | $634 |
2019
| Hospital outpatient clinic visit for assessment and management of a patient | 520 | $47,994 |
| Short return visit (20+ min) | 425 | $8,768 |
| Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, amplified probe technique | 59 | $1,887 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 41 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 40 | $0 |
2018
| Hospital outpatient clinic visit for assessment and management of a patient | 538 | $48,779 |
| Short return visit (20+ min) | 487 | $9,654 |
| Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, amplified probe technique | 132 | $3,925 |
Drugs they prescribed that Part D paid
$18,495
Pharmacies billed $18,495 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 42) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
22 generic and 20 brand-name prescriptions · $18,495 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 14 | $13,281 | $949 |
Year by year
| 2024 | 42 | 17 | 0% (0) | 48% | $18,495 |
| 2023 | 42 | 22 | 0% (0) | 79% | $34,997 |
| 2022 | 21 | 17 | 0% (0) | None | $307 |
| 2021 | 82 | 55 | 0% (0) | None | $1,631 |
| 2020 | 69 | 57 | 0% (0) | None | $983 |
| 2019 | 288 | 218 | None | 6% | $4,052 |
| 2018 | 277 | 215 | None | 4% | $4,402 |
| 2017 | 284 | 210 | None | None | $4,253 |
| 2016 | 428 | 248 | 6% (24) | None | $6,421 |
| 2015 | 192 | 104 | 7% (14) | 9% | $3,440 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Mounjaro | 19 | $20,554 | $1,082 |
| Ozempic | 12 | $11,628 | $969 |
2021: 1 drug
| Amoxicillin-Clavulanate Potass | 15 | $155 | $10 |
2020: 1 drug
| Amoxicillin-Clavulanate Potass | 12 | $111 | $9 |
2019: 8 drugs
| Doxycycline Monohydrate | 27 | $498 | $18 |
| Amoxicillin-Clavulanate Potass | 36 | $407 | $11 |
| Nitrofurantoin Mono-Macro | 11 | $279 | $25 |
| Azithromycin | 22 | $187 | $9 |
| Cephalexin | 33 | $132 | $4 |
| Methylprednisolone | 12 | $92 | $8 |
| Amoxicillin | 16 | $84 | $5 |
| Prednisone | 18 | $57 | $3 |
2018: 7 drugs
| Doxycycline Monohydrate | 34 | $684 | $20 |
| Amoxicillin-Clavulanate Potass | 34 | $421 | $12 |
| Cephalexin | 32 | $168 | $5 |
| Fluticasone Propionate | 11 | $122 | $11 |
| Azithromycin | 17 | $109 | $6 |
| Amoxicillin | 14 | $70 | $5 |
| Prednisone | 16 | $47 | $3 |
2017: 7 drugs
| Doxycycline Monohydrate | 38 | $614 | $16 |
| Amoxicillin-Clavulanate Potass | 34 | $460 | $14 |
| Azithromycin | 24 | $167 | $7 |
| Ciprofloxacin | 17 | $103 | $6 |
| Cephalexin | 25 | $82 | $3 |
| Sulfamethoxazole-Trimethoprim | 13 | $50 | $4 |
| Prednisone | 18 | $45 | $2 |
2016: 11 drugs
| Fluticasone Propionate | 25 | $228 | $9 |
| Doxycycline Monohydrate | 15 | $205 | $14 |
| Azithromycin | 29 | $174 | $6 |
| Amoxicillin-Clavulanate Potass | 16 | $122 | $8 |
| Ibuprofen | 31 | $122 | $4 |
| Ciprofloxacin | 13 | $75 | $6 |
| Prednisone | 35 | $69 | $2 |
| Hydrocortisone | 11 | $66 | $6 |
| Naproxen | 13 | $66 | $5 |
| Cephalexin | 14 | $58 | $4 |
| Tramadol | 17 | $53 | $3 |
2015: 3 drugs
| Ibuprofen | 18 | $79 | $4 |
| Azithromycin | 12 | $76 | $6 |
| Prednisone | 16 | $48 | $3 |
Money from drug and device companies
$71 in 2022
A payment is not proof that care is biased.
| Corium | Azstarys | $33 | 2 payments
|
| Pfizer | Eucrisa | $20 | 1 payment
|
| Ironshore Pharmaceuticals | Jornay Pm | $18 | 1 payment
|
See all 4 published payments
| Pfizer | Meals · 2022-12-21 | Eucrisa | $20 |
| Corium | Meals · 2022-11-29 | Azstarys | $18 |
| Ironshore Pharmaceuticals | Meals · 2022-10-27 | Jornay Pm | $18 |
| Corium | Meals · 2022-08-04 | Azstarys | $15 |
Professional record
- NPI
- 1144665761
- Licence
- OH COA.14449-NP
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X); Federal specialty code 363LP0200X (363LP0200X)
- Mailing address
- 13944 Euclid Ave, East Cleveland, OH, 44112
- NPI first listed
- 2013-05-09
- NPI last updated
- 2023-06-02
- NPI record certified
- 2023-06-02
This is when the NPI record was last certified, not a medical board exam.